PTC Therapeutics PTCT Unrealized Gain (Loss), Foreign Currency Transaction, before Tax
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossUnrealized.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's unrealized gain (loss), foreign currency transaction, before tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's unrealized gain (loss), foreign currency transaction, before tax?
- PTC Therapeutics (PTCT) reported unrealized gain (loss), foreign currency transaction, before tax of $887K in Q1 2026.
- How has PTC Therapeutics's unrealized gain (loss), foreign currency transaction, before tax changed year-over-year?
- PTC Therapeutics's unrealized gain (loss), foreign currency transaction, before tax increased by 139.4% year-over-year, from -$2.25M to $887K.
- What does unrealized gain (loss), foreign currency transaction, before tax mean?
- Measures the non-cash impact of exchange rate fluctuations on monetary assets and liabilities denominated in currencies other than the company's functional currency. This metric provides visibility into the volatility of international operations and the effectiveness of currency risk management.